Spotlight on EMT6-Luc
Learn more about this cell line in our scientific spotlights:
Successful treatment of breast cancer by immunotherapy continues to be a challenge, but emerging clinical data is encouraging.3 To help enable preclinical research of immunotherapy in breast cancer, we have developed the orthotopic EMT6 syngeneic breast tumor model in 2018.